Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer
Clinical trial NCT04675697 · UNKNOWN
Trial details
- NCT number
- NCT04675697
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2020-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.